4//SEC Filing
Shah Pratik 4
Accession 0001209191-22-056445
CIK 0001671858other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 6:00 PM ET
Size
10.4 KB
Accession
0001209191-22-056445
Insider Transaction Report
Form 4
Shah Pratik
Director
Transactions
- Award
Common Stock
2022-11-08+10,156,204→ 10,156,204 total(indirect: By Trust) - Award
Employee Stock Option (right to buy)
2022-11-08+354,570→ 354,570 totalExercise: $1.44Exp: 2031-11-30→ Common Stock (354,570 underlying)
Footnotes (5)
- [F1]Received in exchange for 8,593,116 shares of common stock of ARS Pharmaceuticals, Inc. ("ARS") pursuant to an Agreement and Plan of Merger and Reorganization by and among ARS, the Issuer and Sabre Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"), as amended (the "Merger Agreement"). Under the terms of the Merger Agreement, on November 8, 2022, Merger Sub merged with and into ARS (the "Merger"), with ARS surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of ARS common stock was converted into the right to receive 1.1819 shares of the Issuer common stock. Subsequent to the Merger, the name of the Issuer was changed from Silverback Therapeutics, Inc. to ARS Pharmaceuticals, Inc.
- [F2]These shares are held in a trust for the benefit of the Reporting Person. The Reporting Person is trustee of the trust.
- [F3]The shares subject to the option vest in a series of thirty-six (36) equal monthly installments measured from the vesting commencement date.
- [F4]Received in exchange for a stock option to acquire 300,000 shares of common stock of ARS with the exercise price of $1.70 per share pursuant to the Merger Agreement.
- [F5]Upon the closing of the Merger, each outstanding option to purchase shares of ARS common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock.
Documents
Issuer
ARS Pharmaceuticals, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001580787
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 6:00 PM ET
- Size
- 10.4 KB